NCT02330510.
Trial name or title | Amyloid and Glucose PET Imaging in Alzheimer and Vascular Cognitive Impairment Patients With Significant White Matter Disease (MITNEC C6) |
Target condition and reference standard(s) | Cognitive decline over two years of follow‐up, reference standard not specified |
Index and comparator tests | 18F‐florbetapir |
Starting date | 2014 |
Contact information | Maryam Niapour, maryam.niapour@sunnybrook.ca Christopher JM Scott, christopher.scott@sri.utoronto.ca |
Notes |